RBPJ and MAML3: Potential Therapeutic Targets for Small Cell Lung Cancer
Hideya Onishi(Pancreas Centre (Canada)), Takashi Morisaki(Saiseikai Fukuoka General Hospital), Katsuya Nakamura(Kyushu University), Akira Imaizumi(Ajinomoto (Japan)), Shu Ichimiya(Kyushu University), Shuntaro Nagai(Kyushu University), Masayo Umebayashi(Saiseikai Fukuoka General Hospital), Kosuke Yanai(Kyushu University), Akio Yamasaki(Kyushu University), Hisanobu Ogata(Kyushu University), Mutsunori Murahashi(Jikei University School of Medicine)
Cited by 20
Related Papers
Deletion of the SOCS3 Gene in Liver Parenchymal Cells Promotes Hepatitis–Induced Hepatocarcinogenesis
|Gastroenterology|2006|180
Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors
|Clinical Immunology|2016|62
Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis
|Cancer Immunology Research|2018|36